COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

RSS icon
COVID-19 coronavirus mask smell

Chemical alterations in the brain hint at whether loss of smell will return post-COVID

Researchers have identified what they believe could serve as imaging biomarkers that predict recovery from anosmia after contracting the virus. 

Rakesh Gopinathannair, MD, FAHA, FACC, FHRS, director of cardiac electrophysiology laboratories at the Kansas City Heart Rhythm Institute, explains lessons from the AHA statement on COVID caused arrhythmias.

Key details associated with the treatment of COVID-induced arrhythmias

Rakesh Gopinathannair, MD, lead author of a recent American Heart Association scientific statement on cardiac arrhythmias associated with COVID-19, reviewed the latest science associated with this important topic.

Thumbnail

DEA wants to permanently anchor some COVID-era prescription regulations

The Drug Enforcement Administration is proposing the adoption of some COVID-era prescription practices around certain controlled substances. The agency published a framework to guide any such changes Jan. 17. 

differentiating between malignant and vaccine-related lymphadenopathy

7 COVID vaccine complications: The radiologist's role in identifying adverse reactions

Although serious adverse events related to COVID-19 vaccines are rare, some are life-threatening. It is important that radiologists are aware of how these complications present.

Overview of the pathophysiological mechanisms associated with arrhythmogenesis in the setting of COVID-19 infection. Image from Circulation.

AHA issues a scientific statement on COVID-19 cardiac arrhythmias

The objective of the AHA scientific statement is to review the available evidence on for better management of cardiac arrhythmias from COVID causes that are still encountered on a regular basis.

COVID from a patient's nasal passage. Transmission electron micrograph of SARS-CoV-2 virus particles (gold) within endosomes of a heavily infected nasal olfactory epithelial cell. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Image courtesy of NIAID. What does COVID look like?

History of COVID-19 doubles long-term risk of heart attack, stroke or death

A patient's blood type appears to play a major role in their odds of developing cardiovascular issues after COVID-19, researchers found. 

long covid brainstem damage

Ultra-high field MRI implicates long COVID in brainstem damage

Researchers have used 7T MRI to demonstrate that former COVID-19 inpatients are susceptible to persistent brainstem abnormalities associated with long-haul COVID symptoms.

Monitoring acute heart patients at home linked to considerable cost savings

The new report could go on to help guide decisions made by CMS and hospital leadership teams for years to come.

Displaying 17 - 24 of 953
Design by Adaptive Theme